Vivtex vs Emulate

Side-by-side comparison of AI visibility scores, market position, and capabilities

Emulate leads in AI visibility (74 vs 52)
Vivtex logo

Vivtex

ChallengerBioTech

Oral Biologics Drug Delivery

Signed $2.1B Novo Nordisk collaboration (Feb 2026). Platform enables oral delivery of proteins and peptides (historically injection-only). MIT Langer lab spinout.

AI VisibilityBeta
Overall Score
C52
Category Rank
#67 of 198
AI Consensus
84%
Trend
stable
Per Platform
ChatGPT
52
Perplexity
51
Gemini
50

About

Vivtex is an MIT Langer Laboratory spinout that has developed a drug delivery platform enabling oral administration of biologics — proteins, peptides, and other large molecules — that have historically required injection because they are degraded by stomach acid and too large to absorb through the intestinal wall. In February 2026, Vivtex signed a $2.1 billion collaboration agreement with Novo Nordisk for the development of oral formulations of biologic drugs in obesity, diabetes, and metabolic disease.

Full profile
Emulate logo

Emulate

LeaderLife Sciences & BioTech

Organ-on-Chip & Drug Development Tools

Pioneering organ-on-chip platform installed in 150+ labs including 17 of the top 25 biopharma companies; launched AVA™ high-throughput 96-chip system in 2025 and holds the only FDA ISTAND-accepted DILI Organ-Chip.

AI VisibilityBeta
Overall Score
B74
Category Rank
#8 of 198
AI Consensus
73%
Trend
stable
Per Platform
ChatGPT
78
Perplexity
73
Gemini
77

About

Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the microstructure and function of human organs. Founded in 2013 as a spin-out from the Wyss Institute at Harvard University, Emulate's chips model the liver, intestine, lung, kidney, brain, and other organ systems with a fidelity that animal models and traditional cell culture cannot match. The technology was originally developed to reduce drug development attrition rates caused by poor translation from animal studies to human clinical outcomes.

Full profile

AI Visibility Head-to-Head

52
Overall Score
74
#67
Category Rank
#8
84
AI Consensus
73
stable
Trend
stable
52
ChatGPT
78
51
Perplexity
73
50
Gemini
77
54
Claude
79
47
Grok
68

Key Details

Category
Oral Biologics Drug Delivery
Organ-on-Chip & Drug Development Tools
Tier
Challenger
Leader
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Vivtex
Oral Biologics Drug Delivery

Integrations

Only Vivtex

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.